HIF-1α promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease

HIF‐1α is required for solid tumor formation and embryonic vascularization

Heather E. Ryan · The EMBO Journal · 1998 · 1.6K citations · Full text

Medicine, Developmental Biology, Oncology +14

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst et al. · New England Journal of Medicine · 2012 · 1.6K citations · Full text

Medicine, Nephrology, Pharmacology +14

Expression of Hypoxia-Inducible Factor-1α and -2α in Hypoxic and Ischemic Rat Kidneys

Christian Rosenberger, Stefano J. Mandriota, Jan Steffen JuCombining Diaeresisrgensen et al. · Journal of the American Society of Nephrology · 2002 · 577 citations

Life Sciences, Cell Biology, Physiology +17

Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy

Isaline Rowe, Marco Chiaravalli, Valeria Mannella et al. · Nature Medicine · 2013 · 494 citations

Medicine, Molecular Medicine, Nephrology +16

Acute postnatal ablation of <i>Hif-2</i> α results in anemia

Michaela Gruber, Cheng‐Jun Hu, Randall S. Johnson et al. · Proceedings of the National Academy of Sciences · 2007 · 466 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13